US Stock MarketDetailed Quotes

CRDL Cardiol Therapeutics

Watchlist
  • 2.4100
  • +0.0500+2.12%
Close Jun 14 16:00 ET
  • 2.4700
  • +0.0600+2.49%
Post 19:48 ET
166.29MMarket Cap-7046P/E (TTM)

About Cardiol Therapeutics Company

Cardiol Therapeutics, Inc. is a clinical-stage life sciences company focused on the research and clinical of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. The firm is conducting clinical studies to evaluate the efficacy and safety of CardiolRx in diseases affecting the heart: a Phase II multi-national, randomized, double-blind, placebo-controlled trial (the \"ARCHER\" trial) in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis. It is also involved in developing a novel subcutaneously administered drug formulation of cannabidiol intended for use in heart failure. The company was founded by David Elsley, Eldon Smith, and Anthony Bolton on January 19, 2017 and is headquartered in Oakville, Canada.

Company Profile

SymbolCRDL
Company NameCardiol Therapeutics
Listing DateAug 10, 2021
Founded2017
CEOMr. David G. Elsley
MarketNASDAQ
Employees22
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2265 Upper Middle Road East,Suite 602
CityOakville
ProvinceOntario
CountryCanada
Zip CodeL6H 0G5
Phone1-289-910-0850

Company Executives

  • Name
  • Position
  • Salary
  • David G. Elsley
  • Director, President and Chief Executive Officer
  • 748.10K
  • Christopher J. Waddick, C.A.,C.P.A.
  • Director, Chief Financial Officer and Corporate Secretary
  • 294.80K
  • Dr. Andrew Hamer, M.D.
  • Chief Medical Officer
  • 746.56K
  • Bernard Lim
  • Chief Operating Officer
  • 515.90K
  • Dr. Guillermo Torre-Amione, M.D.,PhD
  • Chairman of the Board
  • 112.68K
  • Colin G. Stott
  • Independent Director
  • 60.00K
  • Teri Loxam
  • Independent Director
  • 82.32K
  • Michael J. Willner
  • Independent Director
  • 71.52K
  • Jennifer Chao
  • Independent Director
  • 76.92K
  • Peter Pekos
  • Independent Director
  • 58.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg